“showed a trend”

More exposure to cytotoxic chemotherapy before osimertinib showed a trend toward systemic PD (20.0% vs. 37.9%, p = 0.05, Table 2 ).

In the airway analysis, the volume increased by 6.2% ( p = 0.327), while the area showed a trend toward improvement (20%; p = 0.050), approaching statistical significance.

However, coadministration of SV and GJ (HSG1) up-regulated the mRNA expressions of iNOS and COX-1 ( p < 0.05) and showed a trend of elevating the mRNA level of COX-2 ( p > 0.05).

Additionally, the TC, TG, LDL-C and HDL-C concentrations in the ε4 carrier control participants showed a trend towards higher levels compared to the DN group (all p > 0.05).

Conversely, D -Fructose concentrations showed a trend towards higher levels in the glucose-loaded group compared to the non-loaded group ( p = 0.05) (Fig. 3B ).

Preincubation with TVA showed a trend to reduce the % of cells expressing ICAM-1 with all the concentrations used, behaving significantly differently from EA ( Figure 9 A–C, p < 0.05, p < 0.0001, and p < 0.001, respectively).

Our analysis of GTEx data revealed that individuals carrying the CC genotype of SNP rs7408174 showed a trend for increased resistin expression, compared with patients who had the wild-type TT homozygous genotype (p<0.05; Fig. 2 ). 4.

Surgical duration ≥120 min showed a trend toward increased risk (OR = 2.12, p = 0.050), warranting caution in prolonged cases.

In contrast, although the free Dex SC group showed a trend towards arthritis reduction, the difference from the positive control group was not significant ( p > 0.05).

In fact, freezing in the trained context showed a trend toward a decline in aged mice from 1 to 30 d ( F (1,83) = 3.9, P = 0.05), reflective of an age-dependent impairment in “systems” memory consolidation (compare light gray bars in Fig. 2 A).

Effects of RP-GABA on growth-related measures under different THI conditions As shown in Supplementary Figure S2 , compared with the control group, RP-GABA supplementation showed a trend toward increased body weight under THI 45, THI 63, and THI 28; however, the differences between groups within each THI condition were not significant ( p > 0.05).

The low-dose resveratrol treatment (20 mg/kg) also showed a trend towards reducing LDH levels in diabetic rats, although the difference between two dosages did not reach statistical significance ( p > 0.05).

Furthermore, at days 1–42, ADG showed a trend ( p < 0.05) of an increase in the ZnO and Zn-Asp groups compared to the CON group.

When comparing the two cohorts at the most recent FU, the reduction in MRC score observed in the Kim's protocol cohort showed a trend toward statistical significance compared to the relapse cohort ( p = 0.0501; Table 2 ). 3.2.2 INCAT disability scale In the relapse cohort we observed a significant reduction in INCAT scores at the FU timepoint compared to the pre-RTX scores (2.58 ± 1.17 vs. 3.21 ± 1.31; p < 0.05; Table 2 ; Figure 1 ).

The interaction between the condition and the number of questions responded showed a trend, F (1,38) = 4.094, p = 0.0501, η 2 = 0.083, such that question answering in the Expressive condition was related to correct identification of target words, while question answering was not related to correct identification of words in the Flat condition.

At three months, the combination group showed a trend toward lower PPBG levels, approaching statistical significance (p = 0.0501).

ANG-1 showed a trend towards significantly shorter TTSP in patients with a FC ≥1.3 ( p = 0.0501).

The exponential curve of NfL plasma concentrations with age showed a trend of being steeper for males than for females (ratio of ratios = 1.00487, 95% CI: [1.00000, 1.00976], p = 0.0502), with an estimated difference per year of 2.775% (95% CI: [2.388%, 3.164%], p < 2.220 × 10 −16 ) for males compared to an estimated difference per year of 2.277% (95% CI: [1.965%, 2.590%], p < 2.220 × 10 −16 ) for females ( Figure 2 C).

Although the univariate intergroup comparison for the top 20 overlapping clones ( Figure 6H ) showed a trend toward expansion of the overlapping CD8 + clones for patients without relapse ( P = .0503), this difference was significant when tested by MVA ( Table 3 ).

Among these, only anti-Parkinson drugs showed a trend toward increased use compared with moderately severe ataxia (18.7% versus 33.9%, p = 0.0503).

Notably, DRB1*04:10:03 showed a trend toward increased frequency in the ICI-ILD group (p = 0.0503).

The type of horse showed a trend in the multivariable analysis, ordinal scale ( p = 0.0643), and was close to significance in the multivariable analysis, nominal scale, ( p = 0.0504) ( Table 2 and Table 5 ).

ARM presence was not significantly associated with viral load or mortality, though recurrent CMV reactivation showed a trend toward association ( p = 0.0504).

For example, patients with musculoskeletal irAEs showed a trend towards an improved median PFS of 12 months (95% CI: 5-NA) compared to 5 months (95% CI: 4–8) ( p = 0.0505) in patients with any other irAE and a statistically significant higher PFS compared to patients without irAE (2 months, 95% CI: 1–8) ( p = 0.0068).

The pooled analysis showed a trend toward improved OS with chemo-immunotherapy (pooled HR 0.78, 95% CI 0.61–1.00; p = 0.0505), although the result missed conventional statistical significance and moderate heterogeneity was observed (I 2 = 50.2%) ( Supplementary Table S1 ).